![Domitille de Vienne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Domitille de Vienne
Direktor/Vorstandsmitglied bei DalCor Pharmaceuticals Canada, Inc.
Aktive Positionen von Domitille de Vienne
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DalCor Pharmaceuticals Canada, Inc.
![]() DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Domitille de Vienne
Statistik
International
Kanada | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
DalCor Pharmaceuticals Canada, Inc.
![]() DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Health Technology |
- Börse
- Insiders
- Domitille de Vienne
- Erfahrung